|
|
 |
RESEARCH FUNDING & GRANTS
Expedition Inspiration raises funds for breast cancer research through locally and nationally organized events and promotions. In order to accomplish our goals, Expedition Inspiration works with eminent medical professionals and researchers at hospitals and national research facilities promoting partnership grants and collaborative funding.
Since its inception in 1997 the Annual Laura Evans Memorial Breast Cancer Symposium has been successful in the sharing of unpublished information and has provoked innovative ideas amount the distinguished scientist who have attended.
$750,000
Young Investigator Awards, participating in the future of research — these grants come at a critical time in the development of the careers of clinical breast cancer scientist and junior faculty members. The attendees of the Symposium nominate the awardees.
Patrick Morris, MD - Memorial Sloan-Kettering Cancer Center
2011 Brenda M. Williams Young Investigator Award for "A Retrospective to Investigate the Prognostic Impact of Inflammation in Women with Breast Cancer.
$15,000
L. Chuck Harrell, PhD - Linegerger Comprehensive Cancer Center - University of North Carolina at Chapel Hill -
2011 Young Investigator Award for "Intrinsically Targeting Breast Cancer in Liver Metastasis".
$15,000
Chloe C. Milson, PhD - Sunnybrook Health Sciences Centre, Department of Cellular Biology, Toronto
2010 Brenda M. Williams Young Investigator Award for “Impact of Chemotherapy-Induced Activation of Platelets on Therapeutic Efficacy Outcomes in Breast Cancer”
$10,000
Toby M Ward, PhD, University of Miami, Leonard M. Miller School of Medicine, Department of Hematology/Oncology
2010 Young Investigator Award for: “Truncated ErbB2 Receptors as Diagnostic and Therapeutic Targets”
$10,000
Bushra Ateeq, PhD Research Fellow/Michigan Center for Translational Pathology / University of Michigan
2009 Outstanding Young Investigator Award for: “The Role of Antiotensin Type 1 Receptor (AGTR1) in a Subset of Breast Cancer”
$10,000
Laura Gonzalez-Malerva, PhD /The Biodesign Institute /Arizona State University
2009 Outstanding Young Investigator Award for: “Functional Genomics and Proteomics for the Understanding of Endocrine Resistance in Breast Cancer”
$10,000
Elizabeth Iorns, PhD / University of Miami, Leonard M. Miller School of Medicine
2008 Outstanding Young Investigator Award for: “Characterization of Breast Stem Cells for
the Identification of Cancer Stem Cell Specific Therapeutic Targets”
$10,000
Jinfeng Suo, PhD / Baylor College of Medicine, Lester and Sue Smith Breast Center
2008 Outstanding Young Investigator Award for: “Duo Regulation of Protein Synthesis and
Degradation by the Int6 Breast Tumor Suppressor”
$10,000
N. Lynn Henry, MD, PhD/University of Michigan
2007 Outstanding Young Research Award for: “Pilot Study to Characterize Musculoskeletal Changes with Ultrasonography in Women with Breast Cancer Treated with Aromatize Inhibitors”
$10,000
Vijayakrishna K. Gadi, MD, PhD / University of Washington
2007 Outstanding Young Research Award for: “Fetal Microchimerism in Normal Human Breast and Breast Cancer”
$10,000
Peter A. Kaufman, MD/Dartmouth-Hitchcock, Norris Cotton Cancer Center
Conducts research through the Molecular Therapeutics Research Program.
$3,500 awarded in 2004 to support Dr. Kaufman
$5,000 granted in 2005 for continued support of Dr. Kaufman
$6,100 granted in 2006 for continued support of Dr. Kaufman
$7,125 granted in 2007 for continued support of Dr. Kaufman
$7,000 granted in 2008 for continued support of Dr. Kaufman
$10,000 granted in 2009 for continued support of Dr. Kaufman
Richard M. Neve, PhD/UCSF Comprehensive Cancer Center
2003 Outstanding Young Research Award for: “ESX: an epithelial-specific Ets transcription factor regulating the metastic potential of human breast cancers”
$10,000
Virginia Kaklamani, MD/ Northwestern University
2003 Outstanding Young Research Award for: “Familial Epidemiologic Study of Polymorphisms of the TGF-B Pathway and Familial Breast Cancer Risk”
$10,000
Kathleen Grant, MD/ California Pacific Medical Center
Stephanie Jeffery. MD/Stanford University
A collaborative grant for: “Comparison of Molecular Markers (Steroid Receptors) in Asian and Caucasian Breast Cancer Patients”
$16,750
Lisa Newman, MD/ Karmanos Cancer Institute
2001 Outstanding Young Researcher Award for: “Feasibility of Evaluating Breast Cancer Patients with Nipple Aspirates and Ductal Lavage”
$20,000
MARC LIPPMAN, MD/ LOMBARDI CANCER CENTER
JOHN PARK, MD/ MT. ZION CANCER CENTER
2000 Collaborative Research Award for: “Development of Anti-EGRI VIII Immunoliposomes for Tumor Specific Drug Delivery”
$20,000
GEORGE VANDE WOUDE, PHD/VAN ANDEL RESEARCH INSTITUTE
MALCOLM MITCHELL, MD/ KARMANOS CANCER INSTITUTE
2000 Collaborative Research Award for: “Development of Breast Cancer Vaccines: New Epitope Identification”
$20,000
MAUREEN CHUNG, MD/ WOMEN AND INFANTS HOSPITAL, PROVIDENCE, RI
2000 Outstanding Young Researcher Award for: “Development if RBCG-IL2MUCI Breast cancer Vaccine”
$25,000
MICHAEL F. PRESS, MD, USC / KENNETH NORRIS COMPREHENSIVE CANCER CENTER - investigating mechanisms for Tumorigenesis in HER-2/neu overexpressing breast cancers.
$50,000 ($25,000 matched by USC / Kenneth Norris Comprehensive Cancer Center)
$50,000 ($25,000 matched by USC/ Kenneth Norris Comprehensive Cancer Center)
$26,000 Granted in 2001 for continued support of Dr. Press.
$33,000 Granted in 2002 for continued support of Dr. Press.
$82,000 Granted in 2003 for continued support of Dr. Press
$23,800 Granted in 2004 for continued support of Dr. Press.
$28,000 Granted in 2005 for continued support of Dr. Press
$23,100 Granted for 2006 for continued support of Dr. Press
$27,000 Granted in 2007 for continued support of Dr. Press
$5,500 Granted in 2008 for continued support of Dr. Press
$5,500 Granted in 2009 for continued support of Dr. Press
TODD WALDMAN, MD, PHD/ THE LOMBARDI CANCER CENTER - for use in the study of somatic cell gene targeting and human tumor suppressor genes to further development of novel anticancer agents.
$10,000
DAITOKU SAKAMURO, MD, THE WISTAR INSTITUTE —
1999 Outstanding Young Researcher Award for:” Research in the area of tumorigenesis pathways including the novel Myc-interacting breast tumor suppressor protein, BIN1”
$10,000
PEGGY PORTER, MD, FRED HUTCHINSON CANCER RESEARCH CENTER
Karen Antman, MD, Columbia Presbyterian and/or Ruth Heimann, University of Chicago —
1999 Collaborative Research Award for: “assessing the viability of CyclinE and p27 as prognostic markers through cooperative research”
$15,000
MOUNTAIN STATES TUMOR INSTITUTE - to support data management of current breast cancer research protocols including bone marrow transplant procedures and the new Southwest Oncology adjuvant protocols.
$4,000
$2,750 granted in 2000 to support further study
$3,300 granted in 2001 to support further study
Helena Chang, MD, Revlon UCLA Breast Center - studies by of biological interventions in breast cancer prevention, diagnosis and treatment.
$50,000 ($25,000 matched by Jonsson Comprehensive Cancer Center)
$50,000 ($25,000 matched by Jonsson Comprehensive Cancer Center)
$26,000 Granted in 2001 for continued support of Dr. Chang
$33,000 Granted in 2002 for continued support of Dr. Chang
$18,000 Granted in 2003 for continued support of Dr. Chang.
$23,800 Granted in 2004 for continued support of Dr. Chang
$28,000 Granted in 2005 for continued support of Dr. Chang
$23,100 Granted for 2006 for continued support of Dr. Chang
OLUFUNMILAYO OLOPADE, MD, UNIVERSITY OF CHICAGO SCHOOL OF MEDICINE
1998 Research Award for:“ assessing the response to treatment of patients with known BRCA1 and BRCA 2 mutations
$15,000
MOUNTAIN STATES MEDICAL RESEARCH INSTITUTE - seed grant for the study of CD40 expression in breast cancer; involvement in cytotoxicity and immune enhancement that may lead to significantly improved cancer treatments.
$15,000
FRED HUTCHINSON CANCER RESEARCH CENTER - the development of community-based high dose chemotherapy programs that can be administered in smaller cancer centers.
$17,000
ANNA MARIA LOPEZ, MD, ARIZONA CANCER CENTER - to study the effect of Neuromuscular Integrative Action of (NIA) on the emotional and physical recovery of women with a history of breast cancer.
$20,000
UCLA/JONSSON COMPREHENSIVE CANCER CENTER - clinical trials utilizing new promising developmental therapies for recurring breast cancer to increase chance of long-term survival.
$30,000 (50% provided through UCLA matching funds)
USC / KENNETH NORRIS COMPREHENSIVE CANCER CENTER - detection of metastatic auxiliary lymph nodes with Positron Emission Tomography to reduce frequency of axillary node dissection and possibility of lymphedema side effect.
$30,000 (50% provided through USC matching funds)
MOUNTAIN STATES TUMOR INSTITUTE - clinical research related to monoclonal antibodies, a promising development in the treatment of breast cancer.
$6000
JINGWEN LIU, PH.D, MOUNTAIN STATES MEDICAL RESEARCH INSTITUTE - Oncosatin M (OM) research, a cytokine produced by white blood cells in the immune system which inhibits growth of breast cancer cells by blocking action of certain factors driving the wild growth of cancer cells.
$10,000
JULIE R. GRALOW, MD, UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE - to study the changes in breast tissue that occur in response to the addition of phytoestrogens to the diet of post-menopausal women to determine if plant estrogens can be a safe and effective alternative to estrogen replacement therapy.
$5,000
$18,500 additionally granted in 2000 to support this study.
$12,000 additionally granted in 2001 to support Dr. Gralow
$10,000 additional grants funds in 2002 supporting Dr. Gralow
$8,500 Granted in 2003 supporting Dr. Gralow
$6,500 Granted in 2004 for additional support for Dr. Gralow.
$15,000 Granted in 2005 for continued support of Dr. Gralow
$5,800 Granted for 2006 to continue to support Dr. Gralow
$3,300 Granted in 2007 to continue to support Dr. Gralow.
USC / KENNETH NORRIS COMPREHENSIVE CANCER CENTER - pilot study on the utility of preoperative chemotherapy for locally advanced breast cancer using the promising new agent Paclitaxel.
$31,100
UCLA/JONSSON COMPREHENSIVE CANCER CENTER - research on whether a change in the composition of fat in the diet, not just the quantity of fat intake, can slow or halt the growth of breast tumors.
$21,100
FRED HUTCHINSON CANCER RESEARCH CENTER - molecular determinants of acquired and intrinsic drug resistance in breast cancer to increase efficacy of adjuvant drug therapies.
$18,000
UNIVERSITY OF WISCONSIN MEDICAL CENTER - studies of a newly discovered natural substance (B-Lapachone derivatives) that kills metastatic breast cancer cells without toxicity to surrounding healthy cells.
$10,000
DANA FARBER CANCER INSTITUTE - DONALD KUFE, MD - Trial using MUC1 gene in a phase I/II test to measure the safety of this vaccine in 18 women with metastatic breast cancer.
$10,000 ($7,500 granted in 2000 for the same study.)
DUKE COMPREHENSIVE CANCER CENTER - Immunotherapy of breast cancer using autologous Dendritic cells pulsed with tumor Antigen.
$20,000
UNIVERSITY OF PENNSYLVANIA CANCER CENTER - phase I trial with TALL-104 cells in-patients with metastatic breast cancer.
$10,000
UCLA/JONSSON COMPREHENSIVE CANCER CENTER - studies as to whether a moderate intensity exercise program can decrease estrogen levels in premenopausal women at high risk for breast cancer.
$10,000
THE WISTAR INSTITUTE - research to isolate human genes associated with the process of metastatic breast cancer as well as continued study into the function of the BRCA 1 gene.
$30,000
FRED HUTCHINSON CANCER RESEARCH CENTER - scrutinizing societal shifts involving diet, exercise and environmental changes that may account for increase in breast cancer incidence.
$25,000
|
|
|
|
|
